AFGAS
BIIB icon

Allegiance Financial Group Advisory Services’s Biogen BIIB Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
+1,200
New +$221K 0.04% 176
2025
Q2 		– Sell
-1,847
Closed -$253K – 158
2025
Q1 		$253K Buy
+1,847
New +$264K 0.08% 109

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allegiance Financial Group Advisory Services's BIIB Position: Q1 2026 in Review

Allegiance Financial Group Advisory Services opened a new position in Biogen (BIIB) in Q1 2026: 1,200 shares worth $220K. The stake represents 0.04% of the portfolio and ranks #176 among its holdings. This is a return to the name: Allegiance Financial Group Advisory Services previously reported a position in BIIB as recently as Q1 2025.

Allegiance Financial Group Advisory Services first reported a position in BIIB in Q1 2025 and has held it in 2 quarters since. The position peaked at $253K in Q1 2025. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Allegiance Financial Group Advisory Services held 1,200 shares of Biogen worth $220K as of Q1 2026.
  • Biogen was a new Allegiance Financial Group Advisory Services position in Q1 2026.
  • Biogen made up 0.04% of Allegiance Financial Group Advisory Services's portfolio in Q1 2026, its #176 holding.
  • Allegiance Financial Group Advisory Services first reported a position in Biogen in Q1 2025 and has held it in 2 quarters since.
  • Allegiance Financial Group Advisory Services's Biogen position peaked at $253K in Q1 2025.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q1 2026, filed 8 May 2026.